The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Breast Cancer Metastasis to Bone: Mechanisms of Osteolysis and Implications for Therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Self-citationSuda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and Expression
Suva, L. J., Winslow, G. A., Wettenhall, R. E. H., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., et al. (1987) · Science · doi:10.1126/science.3616618 · Cited by 1,293
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
Abou-Samra, A. B., Jüppner, H., Force, T., Freeman, M. W., Kong, X. F., Schipani, E., Urena, P., Richards, J., Bonventre, J. V., & Potts, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2732 · Cited by 1,005
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
Self-citationTisdale, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc927 · Cited by 982
Hauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E., & Klagsbrun, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67143-1 · Cited by 869
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Self-citationTGF-β signaling: positive and negative effects on tumorigenesis
Wakefield, L. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00259-3 · Cited by 827
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
Minn, A. J., Kang, Y., Serganova, I. S., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R. G., & Massagué, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522320 · Cited by 742
Parathyroid hormone-related protein purified from a human lung cancer cell line.
Moseley, J. M., Kubota, M., Diefenbach-Jagger, H., Wettenhall, R. E., Kemp, B. E., Suva, L. J., Rodda, C. P., Ebeling, P. R., Hudson, P. J., & Zajac, J. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5048 · Cited by 734
Bone Imaging in Metastatic Breast Cancer
Hamaoka, T., Madewell, J. E., Podoloff, D. A., Hortobagyi, G. N., & Ueno, N. T. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.181 · Cited by 656
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Cited by 650
Fournier, P. G. J., Boissier, S., Filleur, S., Guglielmi, J., Cabon, F., Colombel, M. C., & Clézardin, P. (2002) · PubMed · Cited by 646
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.3.co;2-# · Cited by 609
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.0.co;2-f · Cited by 581
Integrin activation controls metastasis in human breast cancer
Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1853 · Cited by 577
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
Self-citationStrewler, G. J., Stern, P. H., Jacobs, J. W., Eveloff, J., Klein, R. F., Leung, S. C., Rosenblatt, M., & Nissenson, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113275 · Cited by 533
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Honore, P., Luger, N. M., Sabino, M. A. C., Schwei, M. J., Rogers, S. D., Mach, D. B., O'keefe, P. F., Ramnaraine, M. L., Clohisy, D. R., & Mantyh, P. W. (2000) · Nature Medicine · doi:10.1038/74999 · Cited by 498
Molecular mechanisms of cancer pain
Mantyh, P. W., Clohisy, D. R., Koltzenburg, M., & Hunt, S. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc747 · Cited by 477
Guise, T. A., & Mundy, G. R. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0323 · Cited by 472
Self-citationBoucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462
Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 445
Bisphosphonates induce apoptosis in human breast cancer cell lines
Senaratne, S. G., Pirianov, G., Mansi, J. L., Arnett, T. R., & Langrish, V (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1131 · Cited by 428
Bachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 424
Matrix metalloproteinases in tumor–host cell communication
Lynch, C. C., & Matrisian, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700909.x · Cited by 386
Sun, Y.-X., Schneider, A., Jung, Y., Wang, J., Dai, J., Wang, J., Cook, K., Osman, N. I., Koh-Paige, A. J., Shim, H., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041109 · Cited by 384
Bisphosphonates: Clinical Experience
Coleman, R. E. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-14 · Cited by 384
Body, J.-J., Greipp, P., Coleman, R. E., Facon, T., Geurs, F., Fermand, J.-P., Harousseau, J.-L., Lipton, A., Mariette, X., Williams, C. D., et al. (2003) · Cancer · doi:10.1002/cncr.11138 · Cited by 383
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
Yin, J. J., Mohammad, K. S., Käkönen, S. M., Harris, S., Wu-Wong, J. R., Wessale, J. L., Padley, R. J., Garrett, I. R., Chirgwin, J. M., & Guise, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1830978100 · Cited by 381
Self-citationBurtis, W. J., Wu, T., Bunch, C., Wysolmerski, J. J., Insogna, K. L., Weir, E. C., Broadus, A. E., & Stewart, A. F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48217-8 · Cited by 372
A murine model of experimental metastasis to bone and bone marrow.
Arguello, F., Baggs, R. B., & Frantz, C. N. (1988) · PubMed · Cited by 357
Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in Vitro
Horiuchi, N., Caulfield, M. P., Fisher, J. E., Goldman, M. E., McKee, R. L., Reagan, J. E., Levy, J. J., Nutt, R. F., Rodan, S. B., Schofield, T. L., et al. (1987) · Science · doi:10.1126/science.3685994 · Cited by 353
Boissier, S., Magnetto, S., Frappart, L., Cuzin, B., Ebetino, F. H., Delmas, P. D., & Clézardin, P. (1997) · PubMed · Cited by 343
Molecular mechanisms of osteolytic bone metastases
Guise, T. A. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2892::aid-cncr2>3.0.co;2-y · Cited by 331
Self-citationMorony, S., Capparelli, C., Sarosi, I., Lacey, D. L., Dunstan, C. R., & Kostenuik, P. J. (2001) · PubMed · Cited by 318
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
Roudier, M. P., True, L. D., Higano, C. S., Vesselle, H., Ellis, W., Lange, P., & Vessella, R. L. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00190-4 · Cited by 311
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
van der Pluijm, G., Vloedgraven, H., van Beek, E., van der Wee-Pals, L., Löwik, C., & Papapoulos, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118841 · Cited by 305
Delmas, P. D., Balena, R., Confravreux, E., Hardouin, C., Hardy, P., & Bremond, A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.955 · Cited by 278
Bisphosphonates Induce Breast Cancer Cell Death In Vitro
Fromigue, O., Lagneaux, L., & Body, J.-J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.11.2211 · Cited by 276
Käkönen, S.-M., Selander, K. S., Chirgwin, J. M., Yin, J. J., Burns, S., Rankin, W. A., Grubbs, B. G., Dallas, M., Cui, Y., & Guise, T. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202561200 · Cited by 276
Self-citationImmunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
Southby, J., Kissin, M. W., Danks, J. A., Hayman, J., Moseley, J. M., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1990) · PubMed · Cited by 249
Zoledronic Acid Inhibits Visceral Metastases in the 4T1/luc Mouse Breast Cancer Model
Hiraga, T., Williams, P. J., Ueda, A., Tamura, D., & Yoneda, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0325 · Cited by 242
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
Garnero, P., Buchs, N., Zekri, J., Rizzoli, R., Coleman, R. E., & Delmas, P. D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1012 · Cited by 238
Bendre, M. S., Gaddy-Kurten, D., Mon-Foote, T., Akel, N. S., Skinner, R. A., Nicholas, R. W., & Suva, L. J. (2002) · PubMed · Cited by 235
Zhao, W., Byrne, M. H., Boyce, B. F., & Krane, S. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5481 · Cited by 213
Stromal factors involved in prostate carcinoma metastasis to bone
Cooper, C. R., Chay, C. H., Gendernalik, J. D., Lee, H.-L., Bhatia, J., Taichman, R. S., McCauley, L. K., Keller, E. T., & Pienta, K. J. (2003) · Cancer · doi:10.1002/cncr.11181 · Cited by 184
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer
Taube, T., Elomaa, I., Blomqvist, C., Beneton, M. N. C., & Kanis, J. A. (1994) · Bone · doi:10.1016/8756-3282(94)90703-x · Cited by 171
A Role for Curative Surgery in the Treatment of Selected Patients with Metastatic Breast Cancer
Singletary, S. E., Walsh, G., Vauthey, J.-N., Curley, S., Sawaya, R., Weber, K. L., Meric, F., & Hortobágyi, G. N. (2003) · The Oncologist · doi:10.1634/theoncologist.8-3-241 · Cited by 167
Metastatic breast cancer confined to the skeletal system
Sherry, M. M., Greco, F. A., Johnson, D. H., & Hainsworth, J. D. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90286-x · Cited by 160
Scanning electron microscopy in bone pathology: review of methods, potential and applications.
BOYDE, A., Maconnachie, E., Reid, S. A., Delling, G., & Mundy, G. R. (1986) · PubMed · Cited by 159
Vargas, S. J., Gillespie, M. T., Powell, G. J., Southby, J., Danks, J. A., Moseley, J. M., & Martin, J. T. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070814 · Cited by 155
Chemotactic responses of tumor cells to products of resorbing bone.
Orr, W., Varani, J., Gondek, M. D., Ward, P. A., & Mundy, G. R. (1979) · Science · doi:10.1126/science.569363 · Cited by 145
Shakespeare, W. C., Yang, M. G., Bohacek, R. S., Cerasoli, F., Stebbins, K. J., Sundaramoorthi, R., Azimioara, M. D., Vu, C. B., Pradeepan, S., Metcalf, C. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9373 · Cited by 132
van der Pluijm, G., Sijmons, B., Vloedgraven, H. J., Deckers, M. M. L., Papapoulos, S. E., & Löwik, C. W. G. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1077 · Cited by 124
Breast Cancer Metastasis to Bone
Bendre, M. S., Gaddy, D., Nicholas, R. W., & Suva, L. J. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093844.72468.f4 · Cited by 122
Cellular and molecular basis of preferential metastasis of breast cancer to bone
Yoneda, T. (2000) · Journal of Orthopaedic Science · doi:10.1007/s007760050012 · Cited by 100
Iguchi, H., Tanaka, S., Ozawa, Y., Kashiwakuma, T., Kimura, T., Hiraga, T., Ozawa, H., & Kono, A. (1996) · PubMed · Cited by 97
Bone destruction and hypercalcemia in plasma cell myeloma.
Mundy, G. R., & Bertolini, D. R. (1986) · PubMed · Cited by 88
Honoré, P., Luger, N. M., Sabino, M., Schwei, M. J., Rogers, S. D., Mach, D. B., O'keefe, P. F., Ramnaraine, M. I., Clohisy, D. R., & Mantyh, P. W. (2000) · Nature Medicine · Cited by 87
The skeleton as a unique environment for breast cancer cells
Mastro, A. M., Gay, C. V., & Welch, D. R. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022995403081 · Cited by 78
Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo
Gallwitz, W. E., Guise, T. A., & Mundy, G. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0211936 · Cited by 75
Self-citationBone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone.
van der Pluijm, G., Vloedgraven, H. J., Ivanov, B., Robey, F. A., Grzesik, W. J., Robey, P. G., Papapoulos, S. E., & Löwik, C. W. G. M. (1996) · PubMed · Cited by 67
Treatment of Metastatic Bone Disease in Breast Cancer: Bisphosphonates
Diel, I., Solomayer, E.-F., & Bastert, G. (2000) · Clinical Breast Cancer · doi:10.3816/cbc.2000.n.003 · Cited by 62
Toward New Horizons: The Future of Bisphosphonate Therapy
Lipton, A. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-38 · Cited by 53
Yamaguchi, T., Chattopadhyay, N., & Brown, E. M. (1999) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60113-1 · Cited by 49
The role of bisphosphonates in breast cancer
Coleman, R. E. (2004) · The Breast · doi:10.1016/j.breast.2004.09.004 · Cited by 40
Teti, A. M., Migliaccio, S., & Baron, R. (2002) · Calcified Tissue International · doi:10.1007/s00223-001-2071-1 · Cited by 37
Funk, J. L., & Wei, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9568 · Cited by 23
Bisphosphonates for the prevention of bone metastases
Coleman, R. E. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37415 · Cited by 21
Hormone- and chemotherapy-induced bone loss in breast cancer.
Coleman, R. E. (2004) · PubMed · Cited by 14
Cited by
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Langley, R. R., & Fidler, I. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.26031 · Cited by 958
Bone metastasis: the importance of the neighbourhood
Croucher, P. I., McDonald, M. M., & Martin, T. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.44 · Cited by 479
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0234 · Cited by 435
Self-citationThe Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
Wang, H., Yu, C., Gao, X., Welte, T., Muscarella, A. M., Tian, L., Zhao, H., Zhao, Z., Du, S., Tao, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.017 · Cited by 390
Metadata
- Authors
- Kozlow, W., & Guise, T. A.
- Venue
- Journal of Mammary Gland Biology and Neoplasia
- Published
- 2005-04
- Volume
- 10
- Issue
- 2
- Pages
- 169-180
- ISSN
- 1083-3021 (ISSN-L)
- 1573-7039
- OpenAlex
- W2051528631
- Cited by
- 337
- References
- 86
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.